During the last session, Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s traded shares were 0.95 million, with the beta value of the company hitting 1.56. At the end of the trading day, the stock’s price was $2.29, reflecting an intraday loss of -7.66% or -$0.19. The 52-week high for the PHIO share is $10.35, that puts it down -351.97 from that peak though still a striking 33.19% gain since the share price plummeted to a 52-week low of $1.53. The company’s market capitalization is $10.94M, and the average intraday trading volume over the past 10 days was 35.28 million shares, and the average trade volume was 6.13 million shares over the past three months.
Phio Pharmaceuticals Corp (NASDAQ:PHIO) trade information
Phio Pharmaceuticals Corp (PHIO) registered a -7.66% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -7.66% in intraday trading to $2.29, hitting a weekly high. The stock’s 5-day price performance is -36.03%, and it has moved by -8.76% in 30 days. Based on these gigs, the overall price performance for the year is -62.30%. The short interest in Phio Pharmaceuticals Corp (NASDAQ:PHIO) is 51491.0 shares and it means that shorts have 0.5 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 62.38%.
PHIO Dividends
Phio Pharmaceuticals Corp is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Phio Pharmaceuticals Corp (NASDAQ:PHIO)’s Major holders
Phio Pharmaceuticals Corp insiders own 4.81% of total outstanding shares while institutional holders control 3.02%, with the float percentage being 3.17%.
Also, the Mutual Funds coming in first place with the largest holdings of Phio Pharmaceuticals Corp (PHIO) shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Nov 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 4.29 shares. This amounts to just over 0.29 percent of the company’s overall shares, with a $9824.0 market value. The same data shows that the other fund manager holds slightly less at 2.71, or about 0.18% of the stock, which is worth about $6199.0.